USPTO trademark

SYNERGIE GENE+ OUTCOMES

RegisteredUSPTOWord markClass 35

"SYNERGIE GENE+ OUTCOMES" is a word mark owned by Synergie Medication Collective, LLC, filed at the USPTO on June 23, 2023. It is registered and covers class 35 (Advertising and Business).

Get this data via the API
Official USPTO record
SYNERGIE GENE+ OUTCOMES trademark as filed
As filed with the USPTO
Status
Registered
Since January 7, 2025
Filed
June 23, 2023
Registered
January 7, 2025
Expires
Not recorded
Application no.
98055817
Registration no.
7645616
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns SYNERGIE GENE+ OUTCOMES

The owner and representative on file with the office.

Owner

Synergie Medication Collective, LLC

Wilmington, United States

Representative

Patricia I. Reding

Faegre Drinker Biddle & Reath LLP

Goods and services

What the mark covers

The products and services SYNERGIE GENE+ OUTCOMES is filed for, grouped by Nice class.

  • Administering discount group purchasing programs, namely, facilitating and negotiating gene therapy outcomes-based contracts with pharmaceutical manufacturers that require longitudinal patient tracking to assess therapy efficacy and durability, and value-based warranty payments to a risk pool to enable benefit plan participating health care payers to obtain discounts on the purchase of their goods or service

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Notice of acceptance of statement of use e-mailed
  4. Allowed principal register - sou accepted
  5. Statement of use processing complete
  6. Case assigned to intent to use paralegal
  7. Use amendment filed
  8. Teas statement of use received
  9. Noa e-mailed - sou required from applicant
  10. Official gazette publication confirmation e-mailed

10 earlier steps on the official record.

FAQ

About SYNERGIE GENE+ OUTCOMES

Who owns the trademark "SYNERGIE GENE+ OUTCOMES"?

The USPTO trademark "SYNERGIE GENE+ OUTCOMES" (application 98055817) is owned by Synergie Medication Collective, LLC.

What is the status of "SYNERGIE GENE+ OUTCOMES"?

Its status at the USPTO is: registered.

When was "SYNERGIE GENE+ OUTCOMES" registered?

It was registered on January 7, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SYNERGIE GENE+ OUTCOMES and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2bd8-3417-77fb-99d1-0c212a360a6c
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2bd8-3417-77fb-99d1-0c212a360a6c",
  "object": "trademark",
  "mark_text": "SYNERGIE GENE+ OUTCOMES",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98055817",
  "filing_date": "2023-06-23",
  "nice_classes": [
    35
  ],
  "owners": [
    {
      "name": "Synergie Medication Collective, LLC",
      "entity_id": null
    }
  ]
}